Search results
Results From The WOW.Com Content Network
Lercanidipine (trade name Zanidip, among others) is an antihypertensive (blood pressure lowering) drug. It belongs to the dihydropyridine class of calcium channel blockers , which work by relaxing and opening the blood vessels allowing the blood to circulate more freely around the body.
The medical management of CCB toxicity may be difficult. [1] It may not improve with the usual treatments used for a low blood pressure and a slow heart rate. [ 9 ] Those who have no symptoms or signs six hours following taking an immediate release formulation and 24 hours after taking an extended release formulation generally need no further ...
ATC code C08 Calcium channel blockers is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. [1] [2] [3] Subgroup C08 is part of the anatomical group C Cardiovascular system ...
It is advised that those using isradipine not take dolasetron (Anzemet), as both agents can cause a dose-dependent PR interval and QRS complex prolongation. [4]Itraconazole (Onmel/Sporanox) exhibits a negative inotropic effect on the heart and thus could spur an additive effect when used concomitantly with isradipine.
Time management is the process of planning and exercising conscious control of time spent on specific activities—especially to increase effectiveness, efficiency and productivity. [ 1 ] Time management involves demands relating to work , social life , family , hobbies , personal interests and commitments.
A fact from Lercanidipine appeared on Wikipedia's Main Page in the Did you know column on 11 August 2016 (check views). The text of the entry was as follows: The text of the entry was as follows: Did you know ... that grapefruit juice may amplify the antihypertensive effect of lercanidipine ?
The advantages of this system include significantly lower cost of ownership and fewer network and client-side maintenance expenses. However, this architecture has the disadvantage of requiring real-time server access, a need for increased network throughput, and slightly less functionality.
Efonidipine is a dihydropyridine calcium channel blocker marketed by Shionogi & Co. of Japan.It was launched in 1995, under the brand name Landel (ランデル).The drug blocks both T-type and L-type calcium channels. [1]